These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6953915)

  • 1. Characterization of P-component (AP) isolated from amyloidotic tissue: half-life studies of human and murine AP.
    Skinner M; Sipe JD; Yood RA; Shirahama T; Cohen AS
    Ann N Y Acad Sci; 1982; 389():190-8. PubMed ID: 6953915
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
    Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of murine serum amyloid P component by rate nephelometry.
    Gertz MA; Sipe JD; Skinner M; Cohen AS; Kyle RA
    J Immunol Methods; 1984 Apr; 69(2):173-80. PubMed ID: 6201557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of experimental amyloidosis with 131I-labeled serum amyloid P component.
    Caspi D; Zalzman S; Baratz M; Teitelbaum Z; Yaron M; Pras M; Baltz ML; Pepys MB
    Arthritis Rheum; 1987 Nov; 30(11):1303-6. PubMed ID: 3689465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of amyloid P-component (AP) with the amyloid fibril: an updated method for amyloid fibril protein isolation.
    Skinner M; Shirahama T; Cohen AS; Deal CL
    Prep Biochem; 1982; 12(5):461-76. PubMed ID: 6302659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits.
    Hind CR; Collins PM; Caspi D; Baltz ML; Pepys MB
    Lancet; 1984 Aug; 2(8399):376-8. PubMed ID: 6147456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new pentraxin (serum amyloid P-component) in the rat: evidence for two quaternary structures and effect of ligands on self-association.
    Pontet M; D'Asnieres M; Gache D; Escaig J; Engler R
    Biochim Biophys Acta; 1981 Dec; 671(2):202-10. PubMed ID: 7326264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating amyloid-related component in casein-induced murine amyloidosis.
    Baumal R; Sklar S
    J Rheumatol; 1977; 4(3):223-30. PubMed ID: 926100
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
    Zingraff J; Caillat-Vigneron N; Ureña P; Gagné ER; Bererhi L; Moretti JL; Bardin T; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(2):223-9. PubMed ID: 7753457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
    Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A primed state exists in vivo following histological regression of amyloidosis.
    Hawkins PN; Pepys MB
    Clin Exp Immunol; 1990 Aug; 81(2):325-8. PubMed ID: 2387095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay for urinary amyloid P component.
    Maury CP; Teppo AM
    J Lab Clin Med; 1985 Dec; 106(6):619-23. PubMed ID: 3877774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of serum amyloid P component.
    Pepys MB; Baltz ML; de Beer FC; Dyck RF; Holford S; Breathnach SM; Black MM; Tribe CR; Evans DJ; Feinstein A
    Ann N Y Acad Sci; 1982; 389():286-98. PubMed ID: 7046582
    [No Abstract]   [Full Text] [Related]  

  • 15. Amyloid P-component (protein AP) in localized amyloidosis as revealed by an immunocytochemical method.
    Westermark P; Shirahama T; Skinner M; Norén P; Cohen AS
    Histochemistry; 1981; 71(2):171-5. PubMed ID: 7016817
    [No Abstract]   [Full Text] [Related]  

  • 16. Amyloid fibril protein in type I familial amyloidotic polyneuropathy in Japanese.
    Tawara S; Araki S; Toshimori K; Nakagawa H; Ohtaki S
    J Lab Clin Med; 1981 Dec; 98(6):811-22. PubMed ID: 7310224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human amyloid protein: diversity and uniformity.
    Glenner G; Harada M; Isersky C; Cuatrecassas P; Page D; Keiser H
    Biochem Biophys Res Commun; 1970 Nov; 41(4):1013-9. PubMed ID: 4097738
    [No Abstract]   [Full Text] [Related]  

  • 18. Hamster female protein, a sex-limited pentraxin, is a constituent of Syrian hamster amyloid.
    Coe JE; Ross MJ
    J Clin Invest; 1985 Jul; 76(1):66-74. PubMed ID: 4019787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
    Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high resolution ultrastructural study of experimental murine AA amyloid.
    Inoue S; Kisilevsky R
    Lab Invest; 1996 Mar; 74(3):670-83. PubMed ID: 8600318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.